Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France

被引:56
作者
Duong, Mai [1 ]
Salvo, Francesco [3 ,4 ]
Pariente, Antoine [1 ,2 ,3 ]
Abouelfath, Abdelilah [2 ]
Lassalle, Regis [2 ]
Droz, Cecile [1 ,2 ]
Blin, Patrick [2 ]
Moore, Nicholas [1 ,2 ,3 ]
机构
[1] INSERM, U657, Bordeaux, France
[2] CHU Bordeaux CIC P00005, Bordeaux, France
[3] Univ Bordeaux Segalen, F-33076 Bordeaux, France
[4] Ctr Neurolesi Bonino Pulejo, IRCCS, Messina, Italy
关键词
drug-related risks; over-the-counter nonsteroidal anti-inflammatory drugs; prescription nonsteroidal anti-inflammatory drugs; usage patterns; GASTROINTESTINAL COMPLICATIONS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; PATIENT INTERVIEWS; RISK; NSAIDS; IBUPROFEN; METAANALYSIS; CELECOXIB;
D O I
10.1111/bcp.12239
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimsMost risks of nonsteroidal anti-inflammatory drugs (NSAIDs) are pharmacological, dose and duration dependent. Usage patterns of prescription-only (POM) or over-the-counter (OTC)' NSAIDs may influence risks, but are not commonly described. MethodsThe Echantillon Generaliste de Beneficiaires database, the permanent 1/97 representative sample from the French national healthcare insurance systems, was queried over 2009-2010 to identify usage patterns, concomitant chronic diseases and cardiovascular medication in OTC and POM NSAID users. ResultsOver 2 years, 229477 of 526108 patients had at least one NSAID dispensation; 44484 patients (19%) were dispensed only OTC NSAIDs (93% ibuprofen) and 121208 (53%) only POM NSAIDs. The OTC users were younger (39.9 vs. 47.4 years old) and more often female (57 vs. 53%); 69% of OTC users and 49% of POM users had only one dispensation. A mean of 14.6 defined daily doses (DDD) were dispensed over 2 years for OTCvs. 53 for POM; 93% OTCvs. 60% POM patients bought 30 DDD over 2 years, and 1.5 vs. 12% bought 90DDD. Chronic comorbidities were found in 19% of OTC users vs. 28% of POM users; 24 vs. 37% had at least one dispensation of a cardiovascular drug over the 2 years. ConclusionsMost of the use of NSAIDs appears to be short term, especially for OTC-type NSAIDs, such as ibuprofen. The validity of risk estimates for NSAIDs extrapolated from clinical trials or from observational studies not including OTC-type usage may need to be revised.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 51 条
[1]  
[Anonymous], 2000, INT J PHARM PRACT, DOI DOI 10.1111/J.2042-7174.2000.TB00996.X
[2]  
Bhagat K, 2001, East Afr Med J, V78, P507
[3]   Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database [J].
Blin, P. ;
Lassalle, R. ;
Dureau-Pournin, C. ;
Ambrosino, B. ;
Bernard, M. A. ;
Abouelfath, A. ;
Gin, H. ;
Le Jeunne, C. ;
Pariente, A. ;
Droz, C. ;
Moore, N. .
DIABETOLOGIA, 2012, 55 (03) :644-653
[4]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[5]  
de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1
[6]   Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk:: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study [J].
Depont, F. ;
Fourrier, A. ;
Merliere, Y. ;
Droz, C. ;
Amouretti, M. ;
Begaud, B. ;
Benichou, J. ;
Moride, Y. ;
Velo, G. P. ;
Sturkenboom, M. ;
Blin, P. ;
Moore, N. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) :891-900
[7]   The CADEUS study:: methods and logistics [J].
Depont, F. ;
Fourrier, A. ;
Merliere, Y. ;
Droz, C. ;
Amouretti, M. ;
Begaud, B. ;
Benichou, J. ;
Moride, Y. ;
Blin, P. ;
Moore, N. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (05) :571-580
[8]   The pattern of use of non-steroidal anti.-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people [J].
Fosbol, Emil Loldrup ;
Gislason, Gunnar H. ;
Jacobsen, Soren ;
Abildstrom, Steen Z. ;
Hansen, Morten Look ;
Schramm, Tina Ken ;
Folke, Fredrik ;
Sorensen, Rikke ;
Rasmussen, Jeppe N. ;
Kober, Lars ;
Madsen, Mette ;
Torp-Pedersen, Christian .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (08) :822-833
[9]   Celecoxib prescription:: Data from the "Securite Sociale" database of the Aquitaine region, south-western, France [J].
Fourrier-Réglat, A ;
de Bailliencourt, S ;
Molimard, M ;
Latry, P ;
Moore, N ;
Peter, C ;
Bégaud, B .
THERAPIE, 2005, 60 (01) :25-29
[10]  
FUREY SA, 1993, PHARMACOTHERAPY, V13, P143